HC Wainwright Upgrades Caladrius Biosciences To Buy, Sets $1.25 Price Target By: Benzinga via Benzinga April 29, 2016 at 10:16 AM EDT Caladrius Biosciences Inc (NASDAQ: CLBS) has recently entered into a global collaboration agreement with Hitachi Chemical ... Read More >>